Asset Manager

Updated:

AristaMD

Keith Pinter leads AristaMD, a clinical services provider giving PCPs on-demand access to board-certified specialists to compress referral wait times.

AristaMD

AristaMD empowers primary care providers with excellent specialty care - improving patient outcomes with timely, cost-effective access.

General information

Firm type

Asset Manager

Location

Region

North America

Country

United States

City

San Diego

Corporate office

San Diego, CA, United States

Principals

Keith Pinter

Chief Executive Officer

Julia Jezmir

Chief Medical Officer

Mike Gierut

Chief Financial Officer

Kate Cali

Chief Client Officer

Ken Chatfield

Chief Information and Technology Officer

Matt Cerullo

Senior Vice President of Growth

Sector focus

Digital HealthHealthcare Services

Frequently asked questions

Who runs investment decisions at AristaMD?

AristaMD is a private operating company, not an investment firm. Capital allocation and strategic decisions are led by CEO Keith Pinter alongside the executive team and board, which includes representatives from Ascension Ventures, MemorialCare Innovation Fund, and Valeo Ventures.

How does AristaMD source its specialist panel?

The firm contracts a national panel of board-certified specialists using standards conforming to NCQA guidelines. Many panelists are affiliated with academic institutions. AristaMD recruits and credentials these physicians directly rather than relying on open telehealth marketplaces.

Is AristaMD structured as a family office or does it operate more like a venture-backed company?

AristaMD is a venture-backed operating company, not a family office. Its board includes Senior Managing Director John Kuelper of Ascension Ventures, Managing Director Brant Heise of MemorialCare Innovation Fund, and Managing Partner David Eichler of Valeo Ventures, indicating institutional healthcare venture backing.

How is AristaMD related to Ascension Ventures or MemorialCare?

Ascension Ventures and MemorialCare Innovation Fund are represented on AristaMD's board of directors, suggesting they are strategic investors. The relationship positions AristaMD to deploy inside large provider systems affiliated with those health networks, though specific commercial terms are not public.

What is AristaMD's known posture on co-investments alongside external partners?

AristaMD does not publicly disclose co-investment programs. As an operating company rather than an investment platform, its capital activity centers on raising venture rounds and deploying into product and clinical operations rather than syndicating deals.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More San Diego Asset Manager profiles